Clinical Trials Logo

Pelvis Disease clinical trials

View clinical trials related to Pelvis Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05840003 Not yet recruiting - Lung Diseases Clinical Trials

Image Quality: Ultra-Low Dose Scanner Versus Standard Dose Conventional Scanner for Thoraco-abdominopelvic Scans

UL2DLR
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The new image reconstruction algorithm (Precise Image, Philips Healthcare) has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans. The hypothesis is that the images obtained with the Precise Image algorithm for ULD acquisitions are of sufficient and suitable quality for the diagnosis of certain lung, abdominal-pelvic and bone lesions.

NCT ID: NCT03234543 Enrolling by invitation - Liver Diseases Clinical Trials

Remote Ischemic Conditioning in Abdominal Surgery

Start date: October 8, 2017
Phase: N/A
Study type: Interventional

This phase II randomized (1:1) controlled trial will examine the effects of remote ischemic conditioning (RIC) on the outcomes of major abdominal surgery. One hundred subjects will be enrolled at a single institution - University Hospital - Newark. The study population are patients undergoing major abdominal surgery (anticipated to be >/= 2 hrs long with a hospital stay >/= 2 days). Subjects in the treatment group will receive lower limb ischemic conditioning at 3 different time points: before surgery, POD 1 and POD 2. The primary outcome is the 30-day comprehensive complications index (CCI). Key secondary outcomes are changes in systemic inflammatory markers in peripheral blood and 30-day mortality.